Jinxin Fertility Group Limited (“JXR”) reported an on-market repurchase of 6.30 million ordinary shares on 28 May 2026. The shares were bought at prices between HKD 2.13 and HKD 2.17, for a total consideration of HKD 13.58 million.

Following the latest transaction, issued share capital remains at 2.71 billion shares, as all repurchased shares are pending cancellation. Repurchased but not yet cancelled shares now total 42.65 million, equivalent to approximately 1.58 % of the current issued share count.

Under the general mandate granted on 26 June 2025, JXR is authorised to buy back up to 274.47 million shares. To date, 82.31 million shares—representing 2.999 % of the company’s issued shares on the mandate date—have been repurchased on the Hong Kong Stock Exchange.

No treasury shares are being held; all repurchased shares are earmarked for cancellation. A moratorium on new share issues or treasury-share disposals is in place until 27 June 2026, in line with exchange regulations.